Methodology for labeling proteins and peptides with lead-212 (212Pb)
about
Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab.Radioimmunotherapy with α-particle-emitting radionuclides.Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial.Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease.Application of (212)Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.Matching chelators to radiometals for radiopharmaceuticals.A nuclear chocolate box: the periodic table of nuclear medicine.Comparative studies on the therapeutic benefit of targeted α-particle radiation therapy for the treatment of disseminated intraperitoneal disease.B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models.Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.Ra-224 Labeling of Calcium Carbonate Microparticles for Internal α-Therapy: Preparation, Stability and Biodistribution in Mice.212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models.212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.
P2860
Q33761180-8875F96F-8C96-46A2-B59C-F45B9D5DA4D0Q34419562-5AF5D30A-4750-4070-93BB-1D42F8DE7B70Q36105805-03A6692A-2DCA-470A-85C8-6643B3C655E5Q36213374-8F22021C-B964-4301-96B2-9377959BC703Q36551498-90BEC501-4969-418A-BB81-443F62F73F4FQ38156660-1BBF710E-E252-4018-B8AE-107039D24EBEQ38269216-DA7B9268-A2D6-44AB-B6D8-AB39FBBFF52BQ38663041-E628644F-9E88-4546-A333-354C9E6EA579Q38768316-23FB8A34-C856-4033-BA02-77CC2C7E64CDQ47152190-9FD7125B-0BED-401A-8067-6F446FDF57B4Q48144362-51495B5F-126D-4369-AD15-1D60AA082D43Q50138482-41472CF9-8BC1-4CD5-B14A-B226E1F07FE7Q55042518-8DC2FDBD-BDC1-45C9-9774-F017D500D403
P2860
Methodology for labeling proteins and peptides with lead-212 (212Pb)
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Methodology for labeling proteins and peptides with lead-212 (212Pb)
@en
type
label
Methodology for labeling proteins and peptides with lead-212 (212Pb)
@en
prefLabel
Methodology for labeling proteins and peptides with lead-212 (212Pb)
@en
P2093
P2860
P1476
Methodology for labeling proteins and peptides with lead-212 (212Pb)
@en
P2093
Diane E Milenic
Kwamena E Baidoo
Martin W Brechbiel
P2860
P304
P356
10.1016/J.NUCMEDBIO.2013.01.010
P577
2013-04-17T00:00:00Z